Parrish Capital »

Eli Lilly & Co. shares owned by Parrish Capital

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Parrish Capital from 13F filings

Historical chart of Parrish Capital investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Parrish Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Parrish Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $205k 171 1199.43

More positions owned by Parrish Capital

Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Intel Corporation (INTC)
Palo Alto Networks (PANW)
Ge Aerospace Com New (GE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Gilead Sciences (GILD)
Marvell Technology (MRVL)
Qualcomm (QCOM)
Oracle Corporation (ORCL)
Ge Vernova (GEV)
Eaton Corp SHS (ETN)
Astrazeneca Ord (AZN)
Exxon Mobil Corporation (XOM)
Goldman Sachs (GS)

View all positions for Parrish Capital

Top funds holding Eli Lilly & Co.

Lilly Endowment
BlackRock
Vanguard Capital Management
Pnc Financial Services
State Street Corporation
FMR
Capital Research Global Investors
Vanguard Portfolio Management
Geode Capital Management
Capital World Investors
Morgan Stanley
T. Rowe Price Associates
Jpmorgan Chase & Co
UBS Group
Norges Bank Investment Management

View all funds holding Eli Lilly & Co.